Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1631 1632 1657 1799
This examiner grants 24% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18509960 | METHODS OF TREATMENT USING PLURIPOTENT HUMAN ADIPOSE ADULT STEM CELLS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19264712 | UMBILICAL LINING-DERIVED STEM CELLS FOR TREATING IDIOPATHIC INFLAMMATORY MYOPATHY | Final Rejection | RESTEM Group, Inc. |
| 19181809 | MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN DOMESTIC ANIMALS AND IMPROVED CELL CULTIVATION METHODS | Non-Final OA | SCARCELL Therapeutics |
| 19182163 | MAMMALIAN CELL POPULATION AND MENDICAMENTS FOR CELL THERAPIES IN EQUINES AND IMPROVED CELL CULTIVATION METHODS | Non-Final OA | SCARCELL Therapeutics |
| 18484137 | ENGINEERED VASCULAR TISSUE MODELS | Final Rejection | The Johns Hopkins University |
| 16596495 | COMPOSITIONS AND METHODS FOR OBTAINING STEM CELL DERIVED LUNG TISSUE, AND RELATED USES THEROF | Final Rejection | The Regents of the University of Michigan |
| 17867135 | PATCH GRAFT COMPOSITIONS FOR CELL ENGRAFTMENT | Non-Final OA | The University of North Carolina at Chapel Hill |
| 16006460 | PATCH GRAFT COMPOSITIONS FOR CELL ENGRAFTMENT | Final Rejection | The University of North Carolina at Chapel Hill |
| 17257923 | METHODS AND MATERIALS FOR IMPROVING TRANSPLANT OUTCOMES | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17352135 | SYSTEMS AND METHODS FOR MIMICKING A BLOOD VESSEL OF A PATIENT | Non-Final OA | The Texas A&M University System |
| 18078924 | DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY | Non-Final OA | BioVentures, LLC |
| 17050731 | EXTRACELLULAR-MATRIX-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, THREE-DIMENSIONAL TISSUE CONSTRUCT, AND THREE-DIMENSIONAL TISSUE CONSTRUCT FORMATION AGENT | Non-Final OA | OSAKA UNIVERSITY |
| 18463211 | REAGENTS AND METHODS FOR PRODUCING ERYTHROMYELOID PROGENITOR CELLS, NK CELLS, AND MEGAKARYOCYTES | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17510981 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | Non-Final OA | Yale University |
| 18555332 | MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS | Non-Final OA | STEMCELL TECHNOLOGIES CANADA INC. |
| 18734900 | COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS | Final Rejection | Christian VAN DEN BOS |
| 17724986 | REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES | Final Rejection | AVITA Medical Americas, LLC |
| 18194781 | METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE | Non-Final OA | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 17907115 | METHODS AND COMPOSITIONS FOR ALLERGY AND ASTHMA TREATMENT USING FIBROBLASTS | Final Rejection | FIGENE, LLC |
| 18230278 | METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS | Final Rejection | University of Louisville Research Foundation, Inc. |
| 18605731 | METHODS AND COMPOSITIONS FOR MODULATING DOPAMINERGIC NEURONS | Non-Final OA | SanBio, Inc. |
| 16980268 | INDUCTIVE REGENERATION OF THE AIRWAY BY TRANSCRIPTIONAL FACTOR MODULATION OF GLANDULAR MYOEPITHELIAL STEM CELLS | Non-Final OA | University of Iowa Research Foundation |
| 18416698 | COMPOSITIONS AND METHODS FOR PATHOGEN INACTIVATION OF PLATELETS | Non-Final OA | Cerus Corporation |
| 17775172 | Extracellular Matrix Gels, and Organoid Cultures Comprising the Same | Non-Final OA | UCL BUSINESS LTD. |
| 18484426 | ISOLATED RENAL CELLS AND USES THEREOF | Non-Final OA | ProKidney |
| 17675223 | ORGANOIDS COMPRISING ISOLATED RENAL CELLS AND USES THEREOF | Final Rejection | ProKidney |
| 17906165 | METHOD FOR PRODUCING BANKABLE AND SUBCULTURABLE MATURE MICROGLIA | Non-Final OA | CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 17974944 | Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis | Final Rejection | Rhode Island Hospital |
| 18257244 | BIOMARKERS ON CELLULAR ENDOCRINE MODELS FOR ENDOCRINE DISRUPTION ASSESSMENT | Non-Final OA | YSLAB |
| 15654243 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | Final Rejection | Koninklijke Nederlandse Akademie van Wetenschappen |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy